Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (circRNAs) are a special type of RNA that lacks the 5′ and 3’ ends. The functional roles of circRNAs in HCC remain largely unknown. Using high-throughput sequencing, we found several differentially expressed circRNAs in HCC tissues compared with nearby normal tissues. Among them, circRNA derived from the LIFR gene, named circLIFR, was significantly downregulated in HCC. Intriguingly, circLIFR overexpression in SK-Hep-1 cells promoted cell growth and invasion. RNA pull-down and mass spectrometry detection revealed circLIFR interacting with TANK binding kinase 1 (TBK1). Anti-TBK1 RIP confirmed the interaction between circLIFR and TBK1. TBK1 is a ...
Abstract Backgroud Accumulating evidences indicate that circular RNAs (circRNAs), a class of non-cod...
Hepatocellular carcinoma (HCC) is the leading cause of cancer-related deaths worldwide. Despite adva...
Qiang Tu,1,2 Xiaoxiang You,1,2 Jun He,1,2 Xuguang Hu,1,2 Changji Xie,1,2 Guohui Xu1,2 1Department of...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Circular RNAs (circRNAs) have been shown to play an important role in the pathogenesis of hepatocell...
Background: Aberrant expression of circRNAs is involved in the progression of hepatocellular carcino...
Abstract Backgroud Accumulating evidences indicate that circular RNAs (circRNAs), a class of non-cod...
Hepatocellular carcinoma (HCC) is the leading cause of cancer-related deaths worldwide. Despite adva...
Qiang Tu,1,2 Xiaoxiang You,1,2 Jun He,1,2 Xuguang Hu,1,2 Changji Xie,1,2 Guohui Xu1,2 1Department of...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Hepatocellular carcinoma (HCC) is one of the most fatal malignant tumors worldwide. Circular RNAs (c...
Circular RNAs (circRNAs) have been shown to play an important role in the pathogenesis of hepatocell...
Background: Aberrant expression of circRNAs is involved in the progression of hepatocellular carcino...
Abstract Backgroud Accumulating evidences indicate that circular RNAs (circRNAs), a class of non-cod...
Hepatocellular carcinoma (HCC) is the leading cause of cancer-related deaths worldwide. Despite adva...
Qiang Tu,1,2 Xiaoxiang You,1,2 Jun He,1,2 Xuguang Hu,1,2 Changji Xie,1,2 Guohui Xu1,2 1Department of...